Advances in new technologies and innovations have opened the door to a new era of heart disease treatment. The world-class faculty members of the UCLA Adult Interventional Cardiology Program are committed to providing cutting-edge patient care, conduct groundbreaking research, and train the next generation of physicians.
UCLA is a leader in the nation in the treatment of the entire spectrum of cardiovascular conditions. #1 cause of mortality in the US has been Cardiovascular Diseases and a large majority of these arise from blood vessel blockages. Our team at UCLA is expert in prevention, diagnosis, and invasive treatment of these blockages as necessary. In order to accomplish our mission, our cardiac catheterization laboratory serves our patients 24-hours a day, seven days a week, where we perform procedures to diagnose and treat the conditions associated with the cardiovascular system with the newest techniques available. Such procedures include but are not limited to coronary angiogram, fractional flow reserve evaluations, balloon and stenting procedures. We have expert faculty who have extensive experience in rotational, orbital, and laser atherectomy techniques with excellent outcomes.
In addition to treating patients who come in with heart attacks or angina symptoms, we have implemented two state-of-the-art advanced therapy programs recently: Complete Revascularization in High Risk Indicated Patients (CHIP) and Chronic Total Occlusion (CTO). CHIP employs a team approach bringing multidisciplinary specialists together to maximize success and optimize patient outcomes for those who are unable to undergo surgery. Our second program, CTO, aims to provide treatment options to patients who have completely occluded arteries, a procedure deemed too complex for majority of the medical centers.
